title: Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sjögren's syndrome. The MGI PHARMA Sjögren's Syndrome Study Group.
authors.affiliation: Ramsey Clinic & St. Paul Ramsey Medical Center, USA.
authors.forename: J D
authors.initials: JD
authors.lastname: Nelson
authors.forename: M
authors.initials: M
authors.lastname: Friedlaender
authors.forename: R P
authors.initials: RP
authors.lastname: Yeatts
authors.forename: R
authors.initials: R
authors.lastname: Yee
authors.forename: M
authors.initials: M
authors.lastname: McDermott
authors.forename: S
authors.initials: S
authors.lastname: Orlin
authors.forename: S C
authors.initials: SC
authors.lastname: Gallagher
authors.forename: R C
authors.initials: RC
authors.lastname: Shrotriya
mesh_terms: D000284:Administration, Oral; D004311:Double-Blind Method; D006801:Humans; D007638:Keratoconjunctivitis Sicca / Q000188:drug therapy* / Q000503:physiopathology; D008916:Miotics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010862:Pilocarpine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011446:Prospective Studies; D012463:Saliva / Q000187:drug effects / Q000378:metabolism; D012859:Sjogren's Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D014987:Xerostomia / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D008916:Miotics; D010862:Pilocarpine